Navigation Links
Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
Date:10/30/2008

Global Genetic testing market is projected to grow at a healthy pace to exceed $6.6 billion by 2015. The market is primarily driven by growing incidence of genetic diseases and growing consumer awareness and rising interest towards genetic testing.

San Jose, CA (PRWEB) October 30, 2008 -- Genetic testing, which of-late has been transforming itself from service driven to product-driven market is expected to provide an impetus to diagnostic companies with respect to expansion of their operations. Genetic testing market has been witnessing a rise in demand from various quarters, which include medical, paternity & forensics departments, immigration & insurance sectors and DNA banks.

Rising demand and rapid progress in the field of genetic testing has been the prime reason for US maintaining its leading position. The United States and Europe collectively account for about 83% of the global Genetic testing Market, as stated in a recent report published by Global Industry Analysts, Inc. Increasing emphasis on the need to develop new and more effective testing methods is projected to further propel the market growth. Pharmacogenomic Testing market in the US is projected to record the fastest growth at a CAGR of 25% for the period 2000-2010. Genetic tests to screen the newborns are expected to expand immensely over the coming years and have profound effect on clinical outcomes. The early detection of genetic disorders would significantly reduce morbidity as well mortality rates. The market for prenatal and new-born genetic testing market in the US is estimated at US$622 million for 2008.

The genetic testing market is however not devoid of challenges. Factors such as cost and the level of authenticity engaged in screening and detecting methods employed by physicians remain questionable. As each individual's genetic structure differs so do preferences, there is a need to develop a method that can be customized as per individual needs. Another challenge that the industry faces is the urgent need to employ standard regulations with regard to procedures employed during the genetic testing process.

Genetic testing market is highly competitive with several players vying for the market pie. The influx of new players into the lucrative market is further intensifying market competition. Key players profiled in report include Abbott Molecular Inc., Applied Biosystems Inc., AutoGenomics Inc., BioRad Laboratories, Celera Group, Clinical Data, Inc., Genzyme Genetics, Orchid Cellmark, Inc., PerkinElmer Inc., Quest Diagnostics Inc., Roche Diagnostics, Corp., Roche Molecular Diagnostics Inc. and Sciona Ltd.

The report titled "Genetic Testing: A Global Strategic Business Report" published by Global Industry Analysts, Inc. presents comprehensive analyses of major markets including the US, Canada, Japan, Europe and Rest of World. The report offers incisive insights into the economic fundamentals of the industry, market drivers, and trends, in addition to outlining the competitive landscape. Analysis is provided in US$ million for the period 2000-2015. The US market is further analyzed by the following segments - Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine.

For more details about this research report, please visit http://www.strategyr.com/Genetic_Testing_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press@StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/genetic_test/pharmacogenomic_test/prweb1542634.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Sigma-Aldrich Introduces Methylated DNA Quantification Technology for Epigenetic Research
2. Genetic clock makers at UC San Diego publish their timepiece in Nature
3. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
4. Unraveling the genetic picture of lung cancer
5. Large-scale genetic study sheds new light on lung cancer
6. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
7. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
8. FDA Accepts New Drug Application for Bucindolol, A Genetically-Targeted Treatment for Heart Failure From ARCA biopharma
9. Genetically Modified Canola Plantings Reach 90 Percent in Canada
10. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
11. A Better Tomorrow Treatment Center Inc., Forterus Inc.s Behavioral Healthcare Subsidiary, is the First in the Nation to Offer DNA-Customized Treatment for Individuals with a Genetic Predisposition for Addictive Behavior
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
(Date:2/4/2016)... ... , ... Shimadzu Scientific Instruments will showcase several new products, ... sessions, and present on the analysis of mycotoxins and medical cannabis at the ... at the Georgia World Congress Center in Atlanta, Georgia. , Attendees should ...
(Date:2/4/2016)... MONMOUTH JUNCTION, N.J. , Feb. 4, 2016 ... critical care immunotherapy leader commercializing its flagship CytoSorb® ... and cardiac surgery patients around the world, announced ... PhD, will present at the Source Capital Group,s ... overview and update on the company.  ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... leading supplier of Semantic Graph Database technology has been recognized As “ Best ... by Corporate America Magazine. , “At Corporate America, it’s our priority to showcase ...
Breaking Biology Technology:
(Date:1/8/2016)... LOS ANGELES and MANCHESTER, United Kingdom ... ("BBI"), a developer of innovative sensor-based diagnostic products, today ... was financed by new and existing investors.  Proceeds from the ... SEM Scanner , a hand-held device for detecting early-stage ... and Ireland after receiving CE Mark ...
(Date:1/7/2016)... -- This BCC Research report studies the global as ... identifying newer markets and exploring the expansion of the ... Includes forecast from 2015 to 2020. Use ... the expansion of the present application market for various ... technology, determine its current market size, and estimate the ...
(Date:1/7/2016)...  A United States District Court in ... country to interpret a biometric privacy statute in a ... the photo website Shutterfly brought by the law firm Carey ... vs. SHUTTERFLY, INC.; and THISLIFE, INC ( N.D. Ill ... the Illinois Biometric Privacy Act by collecting and scanning ...
Breaking Biology News(10 mins):